[go: up one dir, main page]

HK1067035A - Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use - Google Patents

Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use Download PDF

Info

Publication number
HK1067035A
HK1067035A HK04109958.7A HK04109958A HK1067035A HK 1067035 A HK1067035 A HK 1067035A HK 04109958 A HK04109958 A HK 04109958A HK 1067035 A HK1067035 A HK 1067035A
Authority
HK
Hong Kong
Prior art keywords
diagnostic
therapeutic use
envelope proteins
virus envelope
purified hepatitis
Prior art date
Application number
HK04109958.7A
Other languages
Chinese (zh)
Inventor
Maertens Geert
Depla Erik
Bosman Fons
Original Assignee
Genimmune N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genimmune N.V. filed Critical Genimmune N.V.
Publication of HK1067035A publication Critical patent/HK1067035A/en

Links

HK04109958.7A 2001-12-18 2002-12-18 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use HK1067035A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20510 1993-02-22
US418358P 2002-10-16

Publications (1)

Publication Number Publication Date
HK1067035A true HK1067035A (en) 2005-04-01

Family

ID=

Similar Documents

Publication Publication Date Title
LU91328I2 (en) Human papillomavirus vaccine Ätypes 6,11,16,18Ü (recombinant, adsorbed)
AU2002220460A1 (en) The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
AU2158000A (en) Treatment of hepatitis c virus infections with interleukin-10
IL162236A0 (en) Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use
AU2002237195A1 (en) Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
AU2002333773A1 (en) New hepatitis c virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
AU2002233424A1 (en) Peptides having affinity for the GP120 viral protein and use thereof
AU2281601A (en) Treatment of viral infections using levovirinTM
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection
IL151033A0 (en) Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
AU4554899A (en) Novel hepatitis c virus peptides and uses thereof
AU2002332613A1 (en) Compositions and therapeutic methods for viral infection
HK1067035A (en) Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
HK1067371A (en) Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
AU5611701A (en) Agent for the diagnosis and therapy of viral diseases
AU2002308593A1 (en) Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications
AU2002323443A1 (en) Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
AU7716900A (en) Hcv e2 protein binding agents for treatment of hepatitis c virus infection
AU2003303889A1 (en) Polypeptides f' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof
AU2002367374A1 (en) Expression and purification of atm protein using vaccinia virus
AU2003299493A1 (en) Compositions and methods for the treatment of hepatitis c virus infection
AU2001282560A1 (en) Methods of infection with hepatitis c virus
AU2003250394A1 (en) Use of hepatitis c virus (hcv) p7 protein
AU2002248686A1 (en) Replication-competent recombinant virus and methods of use thereof